Chi-Med hunts for $262m through follow-on
Hutchison China MediTech hit the market on Wednesday with a view to raising around $262m from a follow-on sale of American depository shares (ADS), according to a term sheet seen by GlobalCapital Asia.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: